Recombinant Human RHD Protein, N-His-SUMO

Description of Recombinant Human RHD Protein, N-His-SUMO

Introduction

Recombinant Human RHD Protein, also known as RhD protein, is a type of recombinant protein that plays a crucial role in blood group antigen testing and transfusion medicine. This protein is produced through genetic engineering techniques, making it a valuable tool in various scientific and medical applications. In this article, we will explore the structure, activity, and applications of Recombinant Human RHD Protein.

Structure of Recombinant Human RHD Protein

The structure of Recombinant Human RHD Protein is similar to that of the natural RhD protein found on the surface of red blood cells. It is a transmembrane protein consisting of 417 amino acids, with a molecular weight of approximately 45 kDa. The protein is composed of two domains: the N-terminal extracellular domain and the C-terminal intracellular domain. The extracellular domain contains the antigenic epitopes that are responsible for the RhD blood group system, while the intracellular domain is involved in signal transduction and cell adhesion.

Activity of Recombinant Human RHD Protein

The primary function of Recombinant Human RHD Protein is to serve as an antigen for the RhD blood group system. This system is one of the most clinically significant blood group systems, with over 50 antigens identified to date. The RhD antigen is responsible for the most severe form of hemolytic disease of the newborn, making it crucial for accurate blood typing and transfusion compatibility testing.

Recombinant Human RHD Protein is also used in the production of anti-D antibodies, which are essential for the prevention and treatment of hemolytic disease of the newborn. The protein is expressed in a variety of cell lines, including Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK) cells, to produce high-quality antibodies with minimal risk of contamination.

Applications of Recombinant Human RHD Protein

Recombinant Human RHD Protein has a wide range of applications in the field of transfusion medicine. It is used in blood typing and compatibility testing to accurately determine the RhD status of an individual and ensure safe blood transfusions. This protein is also utilized in the production of anti-D immunoglobulin, which is used to prevent hemolytic disease of the newborn in RhD-negative mothers.

Moreover, Recombinant Human RHD Protein is an essential tool in research and development of new diagnostic tests and therapies for various diseases. Its high purity and specificity make it a valuable reagent in the development of new diagnostic assays for the detection of RhD antigen and antibodies. The protein is also used in the development of novel therapies for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

Conclusion

Recombinant Human RHD Protein is a crucial component in blood group antigen testing and transfusion medicine. Its structure and activity closely resemble that of the natural RhD protein, making it a reliable tool for accurate blood typing and compatibility testing. This protein has a wide range of applications, from preventing hemolytic disease of the newborn to aiding in the development of new diagnostic tests and therapies. With ongoing advancements in genetic engineering techniques, Recombinant Human RHD Protein will continue to play a vital role in the field of transfusion medicine and beyond.